StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Next report date, year-over-year trend, and recent quarter history.
5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.
Factor scoring needs Finnhub-supplied fundamentals — Finnhub returned no fundamental metrics for this ticker. Common for ETFs, foreign filers without US listing depth, recent IPOs, and thinly-traded OTC names.
6-factor scoring with sector-relative rank. Updated daily.
Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-11 | $1.18 | $1.18 | +0.00% | 0.0M |
| 05-12 | $1.18 | $1.18 | +0.00% | 0.0M |
| 05-13 | $1.18 | $1.18 | +0.00% | 0.0M |
| 05-14 | $1.18 | $1.18 | -0.37% | 0.0M |
| 05-15 | $1.12 | $1.19 | +6.25% | 0.0M |
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
Fundamentals not available for HOOK.
No fundamental metrics available yet for this ticker — common for ETFs, foreign issuers without US listing depth, very recent IPOs, or thinly-traded OTC names. The Financials tab pulls from SEC EDGAR directly and may still have data.
| Metric | Q1 2025 2025-03-31 | Annual 2024 2024-12-31 | Q3 2024 2024-09-30 | Q2 2024 2024-06-30 |
|---|---|---|---|---|
Revenue | $2.00M | $43.95M | $42.59M | $37.89M |
Operating Income | $-17.87M | $-51.45M | $-30.00M | $-11.35M |
Net Income | $-15.43M | $-43.50M | $-18.55M | $-19.09M |
EPS (Diluted) | $-1.23 | $-3.47 | $-1.48 | $-0.38 |
Total Assets | $61.26M | $82.55M | $109.73M | $125.05M |
Total Liabilities | $27.18M | $31.33M | $37.93M | $38.98M |
Cash & Equivalents | $40.28M | $39.68M | $59.75M | $77.15M |
Free Cash Flow OCF − CapEx | $32.00K | $-77.17M | $-56.23M | $-38.69M |
Shares Outstanding | 12.54M | 12.54M | 12.54M | 12.54M |
HOOKIPA PHARMA INC
No sell-side coverage available for HOOK.
Common for small-cap names, ETFs, recent IPOs, and ADRs without US-listed sell-side coverage. When analysts publish, ratings appear here within one business day.